A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of ‘good’ cholesterol, despite being treated with statins.
from Top Health News – ScienceDaily http://ift.tt/2i9GqCm
from Tumblr http://ift.tt/2hxLpO3
No comments:
Post a Comment